SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001078782-17-000498
Filing Date
2017-04-17
Accepted
2017-04-17 16:54:30
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ANNUAL REPORT f10k123116_10k.htm 10-K 530607
2 EXHIBIT 23.1 AUDITOR'S CONSENT f10k123116_ex23z1.htm EX-23.1 1495
3 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10k123116_ex31z1.htm EX-31.1 6017
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10k123116_ex32z1.htm EX-32.1 2791
  Complete submission text file 0001078782-17-000498.txt   542029
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54296 | Film No.: 17765104
SIC: 2834 Pharmaceutical Preparations